By MARK LORENZANA The U.S. Food and Drug Administration (FDA) recently announced the acquisition of the bivalent vaccine booster produced by Pfizer-BioNTech against the Omicron variant, as well as the original strain, of the covid-19 virus. Medical experts in Mexico, however, are not too optimistic about the shots arriving in the country anytime soon. “At least in the short term,